Zonisamide
- Product NDC
- 76282-227
- 11-digit product format
- 762820227
- Labeler code
- 76282
- Product ID
- 76282-227_5b700833-52ca-46ef-8874-67b56595db24
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Zonisamide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Exelan Pharmaceuticals, Inc.
- Application
- ANDA077869
- Marketing category
- ANDA
- Marketing start
- 2021-03-15
- Substance
- ZONISAMIDE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 459384H98V | ZONISAMIDE | 68291-97-4 | ZONISAMIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 76282-227-01 | 76282022701 | 100 CAPSULE in 1 BOTTLE (76282-227-01) | 100 capsule | 2021-03-15 | No | No | Historical |